
Acutus Medical AFIB
Quarterly report 2024-Q3
added 11-14-2024
Acutus Medical Total Liabilities 2011-2026 | AFIB
Annual Total Liabilities Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.8 M | 58.4 M | 64.1 M | 66 M | 331 M | 158 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 331 M | 54.8 M | 122 M |
Quarterly Total Liabilities Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.5 M | 40.3 M | 45.7 M | 54.8 M | 53 M | 56.6 M | 55.5 M | 58.4 M | 56.8 M | 61.7 M | 62.9 M | 64.1 M | 63.7 M | 64.7 M | 61.7 M | 66 M | 66 M | 66 M | 66 M | 77.9 M | 77.9 M | 77.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 77.9 M | 40.3 M | 60.9 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
126 M | $ 11.75 | -3.29 % | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 8.98 | -1.32 % | $ 322 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.41 | 0.38 % | $ 121 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
106 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.35 | - | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
14.2 M | $ 100.97 | 1.78 % | $ 1.28 B | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 62.4 | -1.33 % | $ 3.4 B | ||
|
LENSAR
LNSR
|
47.7 M | $ 5.56 | -8.4 % | $ 64 M | ||
|
AxoGen
AXGN
|
92.8 M | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
43.4 B | $ 86.58 | -0.68 % | $ 111 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
10.6 M | $ 24.7 | 0.86 % | $ 209 M | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
InspireMD
NSPR
|
14.2 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Orthofix Medical
OFIX
|
401 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
2.24 M | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
12.7 M | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Penumbra
PEN
|
399 M | $ 334.17 | -0.41 % | $ 13 B | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
27.2 M | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
20.9 M | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.91 | 4.83 % | $ 146 M | ||
|
Quanterix Corporation
QTRX
|
123 M | $ 3.82 | -3.05 % | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
138 M | $ 3.53 | -2.35 % | $ 53.7 K |